Hasil Pencarian - Hariprasad Vankayalapati

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    870 Targeting GCN2 kinase-driven stress response inactivation to restore tumor immunity in metastatic triple negative breast cancer

    870 Targeting GCN2 kinase-driven stress response inactivation to restore tumor immunity in metastatic triple negative breast cancer oleh Hariprasad Vankayalapati, Kyle Medley, Zhaoliang Li, Dongqing Yan, David Bearss, Alana Welm

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Discovery of Novel Inhibitors Targeting Multi-UDP-hexose Pyrophosphorylases as Anticancer Agents

    Discovery of Novel Inhibitors Targeting Multi-UDP-hexose Pyrophosphorylases as Anticancer Agents oleh Yueqin Yang, Hariprasad Vankayalapati, Manshu Tang, Yingbo Zheng, Yingri Li, Cong Ma, Kent Lai

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Use of a bacteriophage lysin to identify a novel target for antimicrobial development.

    Use of a bacteriophage lysin to identify a novel target for antimicrobial development. oleh Raymond Schuch, Adam J Pelzek, Assaf Raz, Chad W Euler, Patricia A Ryan, Benjamin Y Winer, Andrew Farnsworth, Shyam S Bhaskaran, C Erec Stebbins, Yong Xu, Adrienne Clifford, David J Bearss, Hariprasad Vankayalapati, Allan R Goldberg, Vincent A Fischetti

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer.

    The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer. oleh Raffaella Soldi, Tithi Ghosh Halder, Alexis Weston, Trason Thode, Kevin Drenner, Rhonda Lewis, Mohan R Kaadige, Shreyesi Srivastava, Sherin Daniel Ampanattu, Ryan Rodriguez Del Villar, Jessica Lang, Hariprasad Vankayalapati, Bernard Weissman, Jeffrey M Trent, William P D Hendricks, Sunil Sharma

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers

    SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers oleh Zhen Lu, Weiqun Mao, Hailing Yang, Janice M. Santiago-O’Farrill, Philip J. Rask, Jayanta Mondal, Hu Chen, Cristina Ivan, Xiuping Liu, Chang-Gong Liu, Yuanxin Xi, Kenta Masuda, Eli M. Carrami, Meng Chen, Yitao Tang, Lan Pang, David S. Lakomy, George A. Calin, Han Liang, Ahmed A. Ahmed, Hariprasad Vankayalapati, Robert C. Bast Jr.

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: